OHE’s BRAVER Roadmap outlines how adopting a societal perspective in HTA can improve equity, innovation, and health outcomes ...

OHE insight on EQ-5D-5L cognition bolt-on highlights key findings on memory, concentration, self vs proxy reporting, and next ...

OHE insight on Canada's healthcare system, HTA evolution, CDA-AMC drug assessments, and the future of national Pharmacare and ...

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Chris Skedgel and ...

Neil McAuslane PhD, MSc, BSc. Scientific Director of the Centre for Innovation in Regulatory Science (CIRS) overseeing the scientific content of both CIRS regulatory and HTA programmes. Key research ...

Dr Richard Torbett joined ABPI in July 2015 and previously held the role of Executive Director of Economic, Health and Commercial Policy. In this role, Richard was responsible for pricing policy ...

Pedro Pita Barros is the BPI | Fundação “la Caixa” Professor of Health Economics at Nova School of Business and Economics, Universidade Nova de Lisboa. He holds a PhD in Economics and his research ...

Meindert is a highly respected expert in the field of Health Technology Assessment (HTA) with more than 25 years’ experience in the field. Before starting as an independent advisor, Meindert was ...

Oriol has built a career in the planning, policy and decision-making environment, participating not just in the micro management, but also being deeply involved on the meso and macro policy areas.